1.
Shah T, Liddle R, Branch M, Jowell P, Obando J, Poleski M. Pilot Study of Aprepitant for Prevention of Post-ERCP Pancreatitis in High Risk Patients: A Phase II Randomized, Double-Blind Placebo Controlled Trial. JOP [Internet]. 10Sep.2012 [cited 24Apr.2024];13(5):514-8. Available from: http://www.serena.unina.it/index.php/jop/article/view/855